Insider Transactions Reported by 21 Insiders of Keros Therapeutics, Inc.

Symbol
KROS on Nasdaq
Location
Lexington, MA

Insiders trading volume in the past year

Keros Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jasbir Seehra CHIEF EXECUTIVE OFFICER, Director $6,236,898 -$113,433 -1.8% 24 Feb 2026
Jennifer Lachey Chief Scientific Officer $4,307,079 15 Jul 2022
Christopher Rovaldi Chief Operating Officer $2,640,600 18 Feb 2025
Tomer Kariv Director, 10%+ Owner $2,241,983 04 Jun 2025
Ran Nussbaum Director, 10%+ Owner $2,241,983 04 Jun 2025
YUNG H. CHYUNG Chief Medical Officer $1,936,440 18 Feb 2025
Julius Knowles Director $1,927,352 21 Nov 2025
ORBIMED ADVISORS LLC Director $799,761 21 Nov 2025
CARL L. GORDON Director $799,761 21 Nov 2025
Esther Cho SVP, General Counsel $649,994 -$77,581 -11% 18 Feb 2026
Keith Regnante Chief Financial Officer $641,917 -$77,483 -11% 24 Feb 2026
Lorena Raquel Lerner Chief Scientific Officer $508,926 -$63,324 -11% 24 Feb 2026
Charles W. Newton Director $227,826 09 Mar 2026
Pontifax Management 4 G.P. (2015) Ltd. 10%+ Owner $166,110 -$84,975,125 -100% 15 Oct 2025
JEAN JACQUES BIENAIME Director $78,698 09 Mar 2026
Alpna Seth Director $75,810 04 Jun 2025
Nima Farzan Director $75,810 04 Jun 2025
MARY ANN GRAY Director $75,810 04 Jun 2025
ADAR1 Capital Management, LLC 10%+ Owner $0 -$86,194,924 -100% 15 Oct 2025
Simon Peter Cooper Chief Medical Officer 13 Feb 2024
Claudia Ordonez Chief Medical Officer 11 Jun 2021

Recent Insider Transactions by Companies or Individuals for Keros Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.